– Dr. Vicente Riambau
SITE Santiago 2024, 3 – 5 October 2024
Santiago de Compostela, Spain.
– Dr. Vicente Riambau
– Dr. Nilo Mosquera
– Dr. Marc Sirvent
Dr. Vicente Riambau has a Bachelor of Medicine and Surgery from the University of Barcelona and a Doctor of Medicine and Surgery from the Autonomous University of Barcelona. He is head of Vascular Surgery at the Cardiovascular Institute of the Hospital Clínico de Barcelona.
Since 1990 he has been a specialist in Angiology and Vascular and Endovascular Surgery, treating diseases of the circulatory system.
He is currently Professor of Surgery at the University of Barcelona and a member of the most prestigious scientific societies related to vascular surgery around the world. He is Visiting Professor at the Universities of Stanford (USA), Pittsburg (USA) and Belgrade (Serbia). He is Former President of the European Society for Vascular Surgery (ESVS), President of the American Society for Angiology (Spanish Section) and Vice President of the ISVS (International Society for Vascular Surgery). He is a member of 15 editorial committees of international scientific journals and directs the Spanish publication Técnicas Endovasulares.
Founder and President of the Endovascular Foundation. But his main merit is the attention to his patients, to whom he dedicates himself full time.
With the current position as Head of the Angiology and Vascular Surgery Service of the Santiago de Compostela University Hospital Complex and the accumulated experience during the past 5 years as Head of Service in the Ourense Hospital Complex, Dr. Mosquera is responsible for coordinating the clinical research projects associated with the Service and facilitate the work of the professionals who are in it.
The experience accumulated in recent years with more than 200 presentations in International and National congresses support his involvement in Scientific Dissemination, as well as his presence as Guest Professor in more than 100 Courses and Symposiums related to continuing medical training both nationally and internationally in the field of Angiology and Vascular Surgery.
At the moment he is the Principal Coordinating Investigator (PCI) of the prospective INNER-B study; first prospective clinical study carried out in the field of treatment of thoracoabdominal pathology with endovascular techniques.
Marc Sirvent, MD, PhD, FEBVS, is an Angiologist & Vascular & Endovascular Surgeon, with a special focus on the Peripheral Arterial Disease (PAD) & Diabetic Foot. He is recognized by his colleagues & the industry as a reference in the PAD & Diabetic Foot treatment, endorsed by his numerous publications & trials, as well as, the actively training courses to other professionals as Proctor & his participation in workshops, congresses, advisories & many other activities with high impact.
Brief CV:
Marc Sirvent, MD, PhD, FEBVS, has a wide professional & educational career as an Angiologist & Vascular & Endovascular Surgeon, developing his extensive capabilities in different public & private Hospitals. Currently he is the Chief of the Angiology and Vascular Surgery Department at the General University Hospital of Granollers, Catalonia.
During the last years he has focused on the treatment of Peripheral Arterial Disease (PAD) and Diabetic Foot, being the Director of the PAD Program and Head of the Diabetic Foot Unit at the General University Hospital of Granollers, positioning himself as a national & international proctor & reference for other colleges. In this line is an actively consultant for the industry, involving himself in the new products development & evaluation, providing trainings, proctoring, webinars, advisories… to many specialists eager to further their knowledge.
He has a PhD in Surgery and Morphological Sciences from the Autonomous University of Barcelona since July 2024 with the thesis entitled “Outcomes of drug-coated balloon angioplasty after plain or scoring balloon for vessel preparation in patients with femoropopliteal arterial disease”.
He has been author & co-author of numerous national & international publications, as well as, several clinical trials, leading & participating in projects funded by the Intituto de Salud Carlos III. He is also part of consolidated research groups recognized by the Generalitat de Catalunya and the CIBER of CardioVascular diseases.
He directs, organizes, and collaborates in many courses and workshops focused on endoluminal therapy, most of them accredited by the Consell Català de Formació Continuada de les Professions Sanitàries, la Comisión de Formación Continuada del Sistema Nacional de Salud or l’European Accreditation Council for Continuing Medical Education.
8:30 - 10:30
9:00 - 10:30
10:30 - 10:45
10:45 - 11:45
11:45 - 12:45
12:45 - 13:45
11:45 - 13:45
14:00 - 15:00
15:15 - 16:45
16:45 - 17:00
17:00 - 17:45
17:45 - 18:30
18:30 - 19:15
19:15 - 20:00
20:30 -
08:00 - 10:00
08:30 - 10:00
10:00 - 10:30
10:30 - 10:45
10:45 - 11:30
11:30 - 12:10
11:30 - 13:30
12:10 - 13:40
13:40 - 14:10
14:25 - 15:25
15:40 - 16:40
16:00 - 18:00
16:40 - 16:55
16:55 - 17:25
17:25 - 18:25
18:25 - 18:55
18:55 - 19:00
Central European Summer Time (CEST) applies
Please, note that the programme is subject to change, and will be updated continuously up to the symposium.
SITE Barcelona 2023 on-demand content is available online.
You can already access a wide range of session replays and recordings. Access here.